Concepedia

Mary P. Stickelmeyer

MP

Statistics

Publications

6

Citations

349

H-Index

6

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

Bayer (Germany)

PHV Dialysezentrum

National and Kapodistrian University of Athens

National Institute of Health Sciences

Mary P. Stickelmeyer is an author at Eli Lilly (United States) specializing in pharmacy, pharmaceutics, and dissolution testing.

Publications per year

1998–2018

6

Publications

6

FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms

Cynthia K. Brown, Horst Dieter Friedel, Amy R. Barker et al. · AAPS PharmSciTech · 2011 · 120 citations

, , +15

Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism

David McDonnell, Holland C. Detke, Richard F. Bergstrom et al. · BMC Psychiatry · 2010 · 94 citations · Full text

, , +17

FIP Guidelines for Dissolution Testing of Solid Oral Products

Horst Dieter Friedel, Cynthia K. Brown, Amy R. Barker et al. · Journal of Pharmaceutical Sciences · 2018 · 56 citations

, , +14

Self-Association Properties of Monomeric Insulin Analogs Under Formulation Conditions

Jane P. Richards, Mary P. Stickelmeyer, David B. Flora et al. · Pharmaceutical Research · 1998 · 35 citations

, , +10

Stability of U-10 and U-50 Dilutions of Insulin Lispro

Mary P. Stickelmeyer, Casey J. Graf, Bruce H. Frank et al. · Diabetes Technology & Therapeutics · 2000 · 23 citations

, , +15

1–5 of 6